Privi Speciality Chemicals Limited announced the outcome of its Board Meeting held on 3 May 2025.

• The Board approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2025.
• For the financial year ended 31 March 2025, the company reported Standalone Revenue from Operations of ₹ 7,79,047 lakhs and a Net Profit of ₹ 18,852.64 lakhs. Consolidated Revenue from Operations was ₹ 8,17,795.15 lakhs with Net Profit attributable to owners of ₹ 18,685.30 lakhs.
• For the quarter ended 31 March 2025, Standalone Revenue from Operations was ₹ 59,489.93 lakhs and Net Profit was ₹ 6,571.37 lakhs. Consolidated Revenue from Operations was ₹ 61,355.03 lakhs with Net Profit attributable to owners of ₹ 6,647.92 lakhs.
• The Board recommended a Final Dividend of ₹ 5/- (50%) per Equity Share of ₹ 10/- each for the financial year ended 31 March 2025, subject to shareholder approval at the ensuing AGM.
• The 40th Annual General Meeting (AGM) is scheduled for Friday, 1 August 2025.
• The Record Date for determining the entitlement of shareholders for the recommended dividend is Thursday, 24 July 2025.
• The Register of Members and Share Transfer Books will remain closed from Friday, 25 July 2025 to Friday, 1 August 2025 (both inclusive) for the purpose of the AGM.
• The dividend, if approved by shareholders, will be paid within 30 days from the date of the 40th AGM.
• The Board also approved the re-appointment of M/s BSR & Co., LLP as Statutory Auditors for a second term of five years and the appointment of M/s. Rathi & Associates as Secretarial Auditors for a first term of five years, both subject to shareholder approval.